Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Matthew

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Biology & Therapy|December 30, 2009
Reduced cell death, invasive and angiogenic features conferred by BRCA1-deficiency in mammary epithelial cells transformed with H-RasArunasalam Navaraj, Niklas Finnberg, David T Dicker, et al.
Neoplasia (New York, N.Y.)|February 16, 2018
Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR SignalingElizabeth M Matthew, Zhaohai Yang, Suraj Peri, et al.
Cell Cycle (Georgetown, Tex.)|October 4, 2007
Replication stress, defective S-phase checkpoint and increased death in Plk2-deficient human cancer cellsElizabeth M Matthew, Timothy J Yen, David T Dicker, et al.
Cell Cycle (Georgetown, Tex.)|January 8, 2010
The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditionsElizabeth M Matthew, Lori S Hart, Aristotelis Astrinidis, et al.
The Journal of Biological Chemistry|November 24, 2006
CARPs are ubiquitin ligases that promote MDM2-independent p53 and phospho-p53ser20 degradationWensheng Yang, Laura M Rozan, E Robert McDonald, et al.
Oncotarget|December 24, 2015
A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cellsElizabeth M Matthew, Lanlan Zhou, Zhaohai Yang, et al.
Cell Cycle (Georgetown, Tex.)|June 14, 2013
Predicting therapy response in live tumor cells isolated with the flexible micro spring array deviceJean-Nicolas Gallant, Elizabeth M Matthew, Hairong Cheng, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Biology & Therapy|December 30, 2009
Reduced cell death, invasive and angiogenic features conferred by BRCA1-deficiency in mammary epithelial cells transformed with H-RasArunasalam Navaraj, Niklas Finnberg, David T Dicker, et al.
Neoplasia (New York, N.Y.)|February 16, 2018
Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR SignalingElizabeth M Matthew, Zhaohai Yang, Suraj Peri, et al.
Cell Cycle (Georgetown, Tex.)|October 4, 2007
Replication stress, defective S-phase checkpoint and increased death in Plk2-deficient human cancer cellsElizabeth M Matthew, Timothy J Yen, David T Dicker, et al.
Cell Cycle (Georgetown, Tex.)|January 8, 2010
The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditionsElizabeth M Matthew, Lori S Hart, Aristotelis Astrinidis, et al.
The Journal of Biological Chemistry|November 24, 2006
CARPs are ubiquitin ligases that promote MDM2-independent p53 and phospho-p53ser20 degradationWensheng Yang, Laura M Rozan, E Robert McDonald, et al.
Oncotarget|December 24, 2015
A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cellsElizabeth M Matthew, Lanlan Zhou, Zhaohai Yang, et al.
Cell Cycle (Georgetown, Tex.)|June 14, 2013
Predicting therapy response in live tumor cells isolated with the flexible micro spring array deviceJean-Nicolas Gallant, Elizabeth M Matthew, Hairong Cheng, et al.
Pageof 1